Senior insider sale
ADICET BIO, INC. — senior position signals high conviction
$413.1K
64.24K shares
What this filing means
ORBIMED ISRAEL GP LTD. plans to sell 64.24K shares of ADICET BIO, INC. valued at approximately $413.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/7/2026ACC: 0000947871-26-000413
64.24K
Shares to sell
$413.1K
Approx. market value
64.24K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Merger
N/A
9/15/2020
64.24KTotal acquired64.24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2020 | Merger N/A | 64.24K | — |
| Total | 64.24K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
64.24K
Market value
$413.1K
4/7/2026
Total
Units
64.24K
Value
$413.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/7/2026 | 64.24K | $413.1K | Nasdaq Stock Market | Planned |
| Total | 64.24K | $413.1K | ||